Our mission
- Upcoming conferences - March 2022
- 7th Annual Immuno-Oncology Summit Europe 2023
- AACR-2022 NI-2601 & NI-2901 CD47xPD-L1 bispecific antibodies
- AACR-2022 NI-3201 CD28 bispecific antibody platform
- AACR-2023 NI-2901 (CD47xPD-L1) & NI-3201 (CD28xPD-L1) bispecific antibodies
- ASH-2024 generation of FcRH5xCD28 bispecific antibodies
- CD28 bispecific antibodies to be presented at PEGS Europe
- Keystone Symposia – Next Generation Antibody Therapeutics: From Discovery to Patient
- NI-3201, a PD-L1xCD28 bispecific antibody
- PEGS Boston – Advancing Bispecific Antibodies and Combination Therapy to the Clinic
- SITC 2021, NI-2601 & NI-2901 bispecific antibody programs
- SITC 2022, NI-2901 bispecific antibody poster presentation
- Two Light chain Bioscience presentations at Antibody Engineering & Therapeutics Europe
